Found 7 matching trials
Safety and Immunogenicity of the rVSVĪG-ZEBOV-GP Ebola Virus Vaccine Candidate in Children Living in LambarĆ©nĆ©, Gabon
PHASE1LA rVSVĪG-ZEBOV-GP -02-PED is a Phase 1/2, randomized, controlled open labe...
Location
Centre de Recherches MƩdicales de LambarƩnƩ
STRIVE (Sierra Leone Trial to Introduce a Vaccine Against Ebola)
PHASE2The 2014 outbreak of Ebola in West Africa is the largest in recorded histor...
Location
College of Medicine and Allied Health Sciences (COMAHS)
African-Canadian Study of HIV-Infected Adults and a Vaccine for Ebola - ACHIV-Ebola
PHASE2This is a randomized, placebo-controlled, multi-site, double-blind trial of...
Providing Additional Information on the Safety and Effectiveness of an Ebola Vaccine
PHASE3Interventional, single arm, open-label, non-randomized, phase IIIb study to...
Location
Médecins Sans Frontières
Partnership for Research on Ebola VACcinations
PHASE2The purpose of this study is to evaluate the safety and immunogenicity of t...
Location
Centre national de formation et de recherche en santƩ rurale (Maferyniah)
Phase I Trial to Assess the Safety, Tolerability and Immunogenicity of a Ebola Virus Vaccine (rVSVĪG-ZEBOV-GP)
PHASE1The study is designed to establish safety, tolerability and immunogenicity ...
Location
CTC North GmbH & Co. KG
Safety and Immunogenicity of rVSVĪG-ZEBOV-GP Vaccination When Dosed Concurrently With mRNA COVID-19 Vaccine Booster Doses
PHASE4Concurrent vaccination scheduling for key target populations in Rwanda, suc...
Location
Multiple Locations